What is Evonik's updated 2026 adjusted EBITDA guidance, and how does it compare to the previous forecast?

Evonik has raised its 2026 adjusted EBITDA guidance to a range of €2.0 billion to €2.2 billion, up from the prior forecast of €1.7 billion to €2.0 billion. This upward revision reflects the company’s strong Q2 performance and was announced in a statement on June 26.

What was Evonik's adjusted EBITDA in 2025, and how does it relate to the new 2026 outlook?

Evonik’s adjusted EBITDA in 2025 was around €1.9 billion, which falls within both the previous 2026 guidance range (€1.7–€2.0 billion) and the lower end of the newly raised 2026 outlook (€2.0–€2.2 billion), indicating that the company’s 2025 result already approached the prior upper bound and now serves as a foundation for further growth into the revised target zone.

Evonik raises 2026 earnings guidance on strong Q2 performance

Jun 27, 2026

Evonik Industries AG upgraded its 2026 adjusted EBITDA guidance to €2.0–2.2 billion following strong Q2 performance, exceeding prior forecasts of €1.7–2.0 billion.

chemweek

2026-03-10

Evonik Maintains 2026 Profit Forecast

2026-04-28

Evonik to supply membrane technology to bioenergy firm in Malaysia

2026-05-13

Evonik Partners with MTCO for Biogas Purification

2026-05-27

Evonik partners with university in Mexico on solutions for mining industry

2026-06-18

Evonik to Cut 3,200 More Jobs, Discontinue Polyester Business